Crisafulli, Salvatore
Isgrò, Valentina
La Corte, Laura
Atzeni, Fabiola
Trifirò, Gianluca http://orcid.org/0000-0003-1147-7296
Article History
First Online: 15 June 2020
Compliance with Ethical Standards
:
: No sources of funding were used to prepare this article.
: G Trifirò has served on advisory boards for Sandoz, Hospira, Sanofi, Biogen, Ipsen, and Shire; is a consultant for Otsuka; is the principal investigator of observational studies funded by several pharmaceutical companies (e.g., Amgen, AstraZeneca, Daiichi Sankyo, and IBSA) to University of Messina; and is scientific coordinator of the Master’s program ‘Pharmacovigilance, pharmacoepidemiology and pharmacoeconomics: real-world data evaluations’ at University of Messina, which is partly funded by several pharmaceutical companies. Salvatore Crisafulli, Valentina Isgrò, Laura La Corte, and Fabiola Atzeni have no conflicts of interest that are directly relevant to the content of this article.
Free to read: This content has been made available to all.